Zyban may help those who use smokeless tobacco

It has many names: chew, dip, chaw, wad – you name it.  According to estimates by the National Cancer Institute, about 12 million people use smokeless tobacco, a number that has tripled since the 1970s.

“Although not as widespread as cigarette smoking, the use of smokeless tobacco is increasing, especially among youth,” said Elbert Glover, Ph.D., Director of the Tobacco Research Center at West Virginia University.

Now new research shows an anti-smoking medication may help users kick the habit. Zyban is an FDA approved pill that helps smokers kick the habit, but it’s hasn’t been tested on those who use chew until recently.

In a 12 week trial Dr. Glover conducted a study with 70 smokeless tobacco users.  Half of the group took Zyban, the other half took a sugar pill, or placebo.  Patients took Zyban once daily for the first three days, then twice daily thereafter.

At the end of seven weeks, 49% of the patients treated with Zyban had not used tobacco for the previous four weeks versus 26% in the placebo group.  At three months, 40% of the patients on Zyban had still not used tobacco versus 26% of the placebo patients.

While the statistics are encouraging, researchers say more tests are needed.

About Zyban

Zyban is the first nicotine-free prescription medicine available as an aid to quitting smoking and was cleared by the Food and Drug Administration for this use in May 1997.  Unlike nicotine patches or nicotine gum, Zyban does not put more nicotine into your body. With Zyban, you continue to smoke when you first start taking the medication, eventually reaching a quit-date, and taking the drug for a period of time after quitting.

The most common side effects associated with the medication is dry mouth and insomnia.  There is a risk of seizure associated with Zyban, which is increased in certain patients.

Leave a Reply

Generic Viagra, Cialis or Propecia